Profiling of mTORC1 signaling in rat liver using mass spectrometry
Başlık çevirisi mevcut değil.
- Tez No: 401299
- Danışmanlar: DR. PHILIP A. GRUPPUSO
- Tez Türü: Doktora
- Konular: Genetik, Biyokimya, Genetics, Biochemistry
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2011
- Dil: İngilizce
- Üniversite: Brown Unıversıty
- Enstitü: Yurtdışı Enstitü
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
Özet yok.
Özet (Çeviri)
Our understanding of signaling networks in the physiological context of an organism remains limited, partly due to the technical challenge of identifying serine/threonine phosphorylated peptides from complex tissue samples. We have developed a phosphoproteomic strategy to purify, enrich and identify phosphopeptides in rat liver homogenates. We focused on signaling through the mammalian target of rapamycin (mTOR) complex 1 (mTORC1), which is at the center of a nutrient- and growth factor-responsive cell signaling network. Using the immunosuppressant and anticancer drug rapamycin, the only known target of which is mTORC1, we characterized signaling in liver from rats in which the complex was maximally activated using the model of refeeding following 48 hr of starvation. Through a combination of protein and peptide fractionation methods, TiO2 affinity purification of phosphopeptides and mass spectrometry, we reproducibly identified and quantified over four thousand phosphopeptides. Along with 5 known rapamycin-sensitive phosphorylation events, we identified 77 new rapamycin-sensitive candidate phosphorylation sites. Among these were PRAS40 (an Akt substrate), gephyrin, and AMP kinase 2. We observed similar proportions of enhanced and reduced phosphorylation in response to rapamycin. Gene ontology analysis revealed over-representation of mTORC1 sites and translation control sites in rapamycin-sensitive candidates list. These results support the purported physiological role of mTORC1 signaling while identifying new targets within this important signaling network.Protein phosphatase 2A (PP2A) is a major Ser/Thr phosphatase that interacts with a wide array of proteins that regulate its activity, influence substrate specificity, determine intracellular localization and serve as substrates for dephosphrylation. PP2A is involved in many signal transduction pathways. Among them is that involving the mTOR. Through the use of microcystin (MC) affinity purification and MS/MS sequencing, we identified a large number of PP2A subunits and interacting proteins in vivo. Although our preliminary assessment lacked any obvious effects of rapamycin on PP2A complexes, we demonstrated the validity and usefulness of MC affinity purification approach and identified a large number of novel post-translational modifications (PTMs) in both the catalytic and regulatory subunits of PP2A.
Benzer Tezler
- Glioblastoma hücrelerinde mTORC1/2'nin dual hedeflenmesinin globalmetilasyon ve histon modifikasyonları üzerinde yarattığı değişikliklerin incelenmesi
Başlık çevirisi yok
BİLGESU AK
Tıpta Uzmanlık
Türkçe
2025
GenetikEge ÜniversitesiTıbbi Genetik Ana Bilim Dalı
PROF. DR. HALUK AKIN
PROF. DR. ASUDE DURMAZ
- Investigation of RIG-I responses under hypoxic conditions in microglia
Mikroglialarda hipoksik koşullar altında RIG-I yanıtlarının araştırılması
YAĞMUR ÖZÇELEBİ
Yüksek Lisans
İngilizce
2025
Allerji ve İmmünolojiİstanbul Teknik ÜniversitesiMoleküler Biyoloji-Genetik ve Biyoteknoloji Ana Bilim Dalı (disiplinlerarası)
PROF. DR. CEREN ÇIRACI MUĞAN
- CDK inhibitörlerinin mTOR susturması gerçekleştirilen LNCaP, DU145 ve PC3 prostat kanseri hücrelerinde terapotik etkisinin incelenmesi
Investigation of therapeutic effects of the CDK inhibitors on mTOR-silenced LNCaP, DU145 and PC3 prostate cancer cells
ÇAĞRI GÜMÜŞKAPTAN
Yüksek Lisans
Türkçe
2015
Biyolojiİstanbul Kültür ÜniversitesiMoleküler Biyoloji ve Genetik Ana Bilim Dalı
DOÇ. DR. ELİF DAMLA ARISAN
- Targeting circulating breast cancer stem cells via mTOR and WNT inhibitors after bone metastasis
Sirküle meme kanseri kök hücrelerinin kemik metastazı sonrası mTOR ve WNT inhibitörleri ile hedeflenmesi̇
ÖZLEM ALTUNDAĞ ERDOĞAN
Doktora
İngilizce
2025
BiyokimyaHacettepe ÜniversitesiKök Hücre Ana Bilim Dalı
PROF. DR. BETÜL ÇELEBİ SALTIK
- Büyüme ve gelişme geriliği olan çocukların serbest plazma aminoasit profili ve mTOR(Mammalian target of rapamycin) protein düzeyinin araştırılması
Examining the level of free plasma amino acid profiles and mTOR (Mammalian target of rapamycin) protein in the children with growth and developmental delay
MUHAMMED ŞEYHANLI
Tıpta Uzmanlık
Türkçe
2018
Çocuk Sağlığı ve HastalıklarıHarran ÜniversitesiPediatri Ana Bilim Dalı
DR. ÖĞR. ÜYESİ AHMET GÜZELÇİÇEK